Search This Blog

Tuesday, February 18, 2020

Merck KGaA Chosen to Produce Liquid Biopsy Kits

Merck KGaA said Tuesday that it has signed a contract to manufacture liquid biopsy kits for Swedish diagnostics business Elypta.
The kits will be used to detect biological markers for cancer, the German company said.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)